drugset / Trial / NCT01775137
Ext. Long-term Safety Study in CF Patients: Single Arm TIP
Non-randomizedSingle-groupOpen-label
Summary
The purpose of this extension study is to collect additional 48 weeks of safety data from patients taking TIP who have completed the core study CTBM100C2401. The purpose of collecting second year safety data through this study is to obtain long-term (2 years) safety data of TIP.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tobramycin | Small molecule | 112 mg | Inhaled |
Indications
No indication recorded.